Covidien Q4 Profit Beats View on Strong Device Sales (COV)

By
A A A
Share |

Healthcare products maker Covidien plc ( COV ) on Tuesday posted better-than-expected fourth quarter earnings, driven by higher sales of its medical devices.

The Dublin, Ireland-based company reported fiscal fourth quarter net income of $443 million, or 89 cents per share, compared with just $56 million, or 11 cents per share, in the year-ago period. Excluding one-time items, adjusted profit was 84 cents per share.

Revenue rose 3% from last year to $2.67 billion.

On average, Wall Street analysts expected a smaller profit of 74 cents per share, on slightly lower revenue of $2.64 billion.

Covidien shares rose $1.35, or +3.3%, in premarket trading Tuesday.

The Bottom Line
Shares of Covidien ( COV ) have a 1.93% dividend yield, based on last night's closing stock price of $41.35. The stock has technical support in the $37-$38 price area. If the shares can firm up, we see overhead resistance around the $44 price level.

Covidien plc ( COV ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.3 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Created by Dividend.com


This article appears in: Investing , Stocks

Referenced Stocks: COV

Dividend.com

Dividend.com

More from Dividend.com:

Related Videos

Stocks

Referenced

67%

Most Active by Volume

210,395,138
  • $10 ▼ 19.22%
96,887,808
  • $16.99 ▲ 1.13%
95,228,035
  • $75.86 ▼ 6.08%
56,807,621
  • $11.21 ▼ 4.02%
49,508,265
  • $107.34 ▲ 0.56%
43,870,160
  • $3.35 ▲ 0.60%
39,156,225
  • $42.08 ▼ 3.88%
37,305,534
  • $99.81 ▼ 0.37%
As of 10/29/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com